跳至主要内容
临床试验/ACTRN12605000137695
ACTRN12605000137695终止3 期

A Multicentre Randomised Controlled Trial Comparing Two Strategies for the Diagnosis of Invasive Aspergillosis in High-Risk Haematology Patients

Australasian Leukaemia and Lymphoma Group0 个研究点目标入组 240 人开始时间: 2005年8月12日最近更新:

试验速览

阶段
3 期
状态
终止
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1.Undergoing allogeneic haematopoietic stem cell transplantation (HSCT) for any reason OR Undergoing intensive combination chemotherapy for acute myeloid leukaemia (AML) or acute lymphoblastic leukaemia (ALL). 2.Has given written informed consent. Non-English speaking patients are eligible once written informed consent is obtained via the appropriate interpreter.

排除标准

  • 1.Other immunocompromised states (e.g. HIV infection, solid organ transplantation, autoimmune conditions treated with immunosuppressants etc.) besides those outlined in the inclusion criteria above. 2.Currently enrolled in an antifungal treatment trial (not an antifungal prophylaxis trial). 3.Past history of proven or probable IA (as per standardized definitions) during a previous cycle of chemotherapy. 4.Currently have active IA or other active invasive fungal infection. 5.Prior enrolment in this study.

研究者

发起方
Australasian Leukaemia and Lymphoma Group

相似试验

A Multicentre Randomised Controlled Trial Comparing... | 临床试验